These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12377578)

  • 1. Monoamine transporter pharmacology and mutant mice.
    Gainetdinov RR; Sotnikova TD; Caron MG
    Trends Pharmacol Sci; 2002 Aug; 23(8):367-73. PubMed ID: 12377578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine transporters: from genes to behavior.
    Gainetdinov RR; Caron MG
    Annu Rev Pharmacol Toxicol; 2003; 43():261-84. PubMed ID: 12359863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of monoamine transporters.
    Glatt CE; Reus VI
    Pharmacogenomics; 2003 Sep; 4(5):583-96. PubMed ID: 12943466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice.
    Zwart R; Verhaagh S; Buitelaar M; Popp-Snijders C; Barlow DP
    Mol Cell Biol; 2001 Jul; 21(13):4188-96. PubMed ID: 11390648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The developing use of heterozygous mutant mouse models in brain monoamine transporter research.
    Kalueff AV; Ren-Patterson RF; Murphy DL
    Trends Pharmacol Sci; 2007 Mar; 28(3):122-7. PubMed ID: 17275930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders.
    Hahn MK; Blakely RD
    Pharmacogenomics J; 2002; 2(4):217-35. PubMed ID: 12196911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.
    Hoffman BJ; Hansson SR; Mezey E; Palkovits M
    Front Neuroendocrinol; 1998 Jul; 19(3):187-231. PubMed ID: 9665836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of glial monoamine transporters in the central nervous system].
    Inazu M; Takeda H; Matsumiya T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Aug; 23(4):171-8. PubMed ID: 13677912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitter transporters as molecular targets for addictive drugs.
    Amara SG; Sonders MS
    Drug Alcohol Depend; 1998; 51(1-2):87-96. PubMed ID: 9716932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.
    Jayanthi LD; Ramamoorthy S
    AAPS J; 2005 Oct; 7(3):E728-38. PubMed ID: 16353949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
    Xie Z; Westmoreland SV; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems.
    Luethi D; Hoener MC; Liechti ME
    Eur J Pharmacol; 2018 Jan; 819():242-247. PubMed ID: 29225192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The family of Na+/Cl- neurotransmitter transporters.
    Nelson N
    J Neurochem; 1998 Nov; 71(5):1785-803. PubMed ID: 9798903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of mephedrone analogs and related new psychoactive substances.
    Luethi D; Kolaczynska KE; Docci L; Krähenbühl S; Hoener MC; Liechti ME
    Neuropharmacology; 2018 May; 134(Pt A):4-12. PubMed ID: 28755886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Function of monoamine neurotransmitter transporters].
    Sasa M
    Nihon Rinsho; 2001 Aug; 59(8):1457-64. PubMed ID: 11519142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacology of monoamine neurotransmitter transporters].
    Dohi T; Kitayama S; Kumagai K; Hashimoto W; Morita K
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(5):315-26. PubMed ID: 12491807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters.
    Kocabas AM; Rudnick G; Kilic F
    J Neurochem; 2003 Jun; 85(6):1513-20. PubMed ID: 12787070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC; Gu H; Rudnick G
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines.
    Pörzgen P; Park SK; Hirsh J; Sonders MS; Amara SG
    Mol Pharmacol; 2001 Jan; 59(1):83-95. PubMed ID: 11125028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter mutant mice in experimental neuropharmacology.
    Gainetdinov RR
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):301-13. PubMed ID: 18057916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.